White Paper

Maximize Your R&D Investment In DHTs Through The Collection And Retention Of Raw Sensor Data

Source: ActiGraph
Digital Transformation

Advances in sensor technology and data science have revolutionized the ability to remotely obtain and analyze clinically relevant information from individuals. Remote sensor data collected from Digital Health Technologies (DHTs) has the potential to overcome the challenges of suboptimal clinical outcomes in clinical investigation and offer patient-centric, objective clinical outcomes. Sensor-based DHTs, however, involve complex processing steps (algorithms) that can be confusing to clinical trialists who are used to working with patient reported outcomes (PRO) and clinician reported outcomes (ClinRO) collected during intermittent study visits. Through the last 20 years of supporting clinical research, we have learned that one of the key factors when using sensor-based DHTs for clinical investigation is the collection and retention of raw sensor data.

In this white paper, we clarify the myths about raw data and discuss why raw data is essential to maximize the clinical insights and the investment made into the clinical trials.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader